FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF DOXOFYLLINE MUCOADHESIVE BUCCAL TABLETS Authors: R Vinoth , S. RANI AND V. MANIKANDAN
ABSTRACT
The formulation of Doxofylline buccal tablets was the primary goal of this research, which used
different acceptable mucoadhesive polymers, such as Carbopol 934P and HPMC. An impermeable
backing layer of ethyl cellulose was used. The direct compression technique was used to make six
batches of doxofylline mucoadhesive buccal tablets. Physicochemical characteristics like tablet
thickness, friability, drug content, weight variation, surface pH and swelling index were then assessed
and in vitro dissolution test were also carried out in accordance with IP 2018. All of the prepared
tablets were under the permitted limit as stated in IP 2018. The batch 1 (95.81 percent) guaranteed a
long-term release of the medication and a proper swelling index (73.70 percent). Thus, the findings
showed that doxofylline can be made into a buccal mucoadhesive tablet. Furthermore, the properties
of the tablet are not only influenced by the concentration of the polymers, but also by their behaviour.
Keywords: Doxofylline, Mucoadhesive Buccal tablet, Carbopol 934P, HPMC Publication date: 01/09/2022 https://ijbpas.com/pdf/2022/September/MS_IJBPAS_2022_6422.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2022/11.9.6422